Class IIa HDAC inhibition promotes an anti-tumor macrophage phenotype that induces breast tumor regression and inhibits metastasis

被引:0
|
作者
Guerriero, Jennifer L. [1 ]
Sotayo, Alaba [1 ]
Ponichtera, Holly [1 ]
Pourzia, Alexandra [1 ]
Schad, Sara [1 ]
Carrasco, Ruben [1 ]
Suzan, Lazo [1 ]
Bronson, Roderick [2 ]
Letai, Anthony [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
关键词
D O I
10.1158/2326-6074.TUMIMM16-A40
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A40
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Class IIa HDAC inhibition promotes an anti-tumor macrophage phenotype that induces breast tumor regression and inhibits metastasis
    Guerriero, Jennifer L.
    Sotayo, Alaba
    Ponichtera, Holly E.
    Castrillon, Jessica A.
    Pourzia, Alexandra L.
    Schad, Sara
    Johnson, Shawn F.
    Carrasco, Ruben D.
    Lazo, Suzan
    Bronson, Roderick T.
    Davis, Scott P.
    Lobera, Mercedes
    Nolan, Michael A.
    Letai, Anthony
    CANCER RESEARCH, 2018, 78 (04)
  • [2] Class IIa HDAC inhibition promotes an anti-tumor macrophage phenotype that induces breast tumor regression and inhibits metastasis
    Guerriero, Jennifer
    Sotayo, Alaba
    Ponichtera, Holly
    Castrillon, Jessica
    Pourzia, Alexandra
    Schad, Sara
    Johnson, Shawn
    Carrasco, Ruben
    Lazo, Suzan
    Bronson, Roderick
    Davis, Scott
    Lobera, Mercedes
    Nolan, Michael
    Letai, Anthony
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [3] Class IIa HDAC inhibition promotes an antitumor macrophage phenotype that induces breast tumor regression and inhibits metastasis
    Guerriero, Jennifer L.
    Sotayo, Alaba
    Ponichtera, Holly
    Pourzia, Alexandra
    Schad, Sara
    Carrasco, Ruben
    Lazo, Suzan
    Bronson, Roderick
    Letai, Anthony
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [4] Class IIa HDAC inhibition promotes an antitumor macrophage phenotype that induces breast tumor regression and inhibits metastasis
    Guerriero, Jennifer L.
    Sotayo, Alaba
    Ponichtera, Holly E.
    Castrillon, Jessica A.
    Pourzia, Alexandra L.
    Schad, Sara
    Johnson, Shawn F.
    Carrasco, Ruben D.
    Lazo, Susan B.
    Bronson, Roderick T.
    Davis, Scott P.
    Lobera, Mercedes X.
    Nolan, Michael A.
    Letai, Anthony
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [5] Combination of MYC and class IIa HDAC inhibition potentiates anti-tumor efficacy in non-small cell lung cancer
    Park, Jina
    Vaz, Michelle
    Yen, Ray-Whay C.
    Baylin, Stephen B.
    Topper, Michael J.
    CANCER RESEARCH, 2022, 82 (12)
  • [6] Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression
    Olga Radkevich-Brown
    Marie P. Piechocki
    Jessica B. Back
    Amy M. Weise
    Shari Pilon-Thomas
    Wei-Zen Wei
    Cancer Immunology, Immunotherapy, 2010, 59 : 409 - 417
  • [7] Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression
    Radkevich-Brown, Olga
    Piechocki, Marie P.
    Back, Jessica B.
    Weise, Amy M.
    Pilon-Thomas, Shari
    Wei, Wei-Zen
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (03) : 409 - 417
  • [8] Inhibiting MNK kinases promotes macrophage immunosuppressive phenotype to limit anti-tumor immunity.
    Pham, Thao N. D.
    Spaulding, Christina
    Shields, Mario A.
    Khalafalla, Mahmoud G.
    Principe, Daniel R.
    Bentrem, David J.
    Munshi, Hidayatullah G.
    CANCER RESEARCH, 2021, 81 (22) : 34 - 34
  • [9] Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis
    Egberts, Jan-Hendrik
    Cloosters, Vera
    Noack, Andreas
    Schniewind, Bodo
    Thon, Lutz
    Klose, Stefanie
    Kettler, Bastian
    von Forstner, Corinna
    Kneitz, Christian
    Tepel, Juergen
    Adam, Dieter
    Wajant, Harald
    Kalthoff, Holger
    Trauzold, Anna
    CANCER RESEARCH, 2008, 68 (05) : 1443 - 1450
  • [10] Modulation of macrophages in breast tumors towards an anti-tumor phenotype
    Guerriero, Jennifer L.
    Letai, Anthony
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)